XML 62 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Oct. 01, 2011
Oct. 02, 2010
Oct. 02, 2010
Ergotron, Inc
Oct. 03, 2009
Ergotron, Inc
Dec. 31, 2009
Ergotron, Inc
Dec. 31, 2008
Ergotron, Inc
Dec. 31, 2007
Ergotron, Inc
Dec. 19, 2009
Predecessor
Dec. 31, 2008
Predecessor
Dec. 31, 2009
Successor
Dec. 31, 2010
Successor
Cash flows from operating activities:                      
Net (loss) earnings $ (55,100,000) $ (3,300,000) $ 14,139,565 $ 8,189,694 $ 11,264,057 $ 1,519,041 $ 5,674,299 $ 195,300,000 $ (780,700,000) $ (3,400,000) $ (13,400,000)
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:                      
Deferred income tax         1,849,433 (2,219,353) 36,579        
Depreciation and amortization expense 71,800,000 72,700,000     4,794,696 4,054,284 3,374,330 57,700,000 68,600,000 6,200,000 91,700,000
Equity in income of unconsolidated affiliate           0 (125,767)        
Loss from debt retirement 33,800,000 0           0 9,900,000 0 0
Non-cash interest expense, net 4,100,000 1,400,000           45,500,000 8,300,000 0 2,100,000
Gain on settlement of liabilities subject to compromise 0 0           (539,900,000) 0 0 0
Elimination of Predecessor deferred debt expense and debt discount 0 0           42,600,000 0 0 0
Non-cash fresh-start accounting adjustments 0 0           (131,000,000) 0 0 0
Non-cash goodwill impairment charge 0 0           284,000,000 710,000,000 0 0
Non-cash write-down of foreign subsidiaries 0 0           2,800,000 3,300,000 0 0
Non-cash share-based compensation expense 400,000 1,900,000     188,588 166,774 97,162 100,000 100,000 0 2,800,000
Excess tax benefits from stock-based compensation         (545,939)            
Other         63,950 (80,857) (31,015)        
Gain on sale of property and equipment (100,000) (200,000)           0 (2,700,000) 0 (200,000)
Deferred federal income tax (benefit) provision (27,200,000) (27,300,000)           65,200,000 11,100,000 (1,300,000) (18,800,000)
Changes in certain assets and liabilities, net of effects from acquisitions:                      
Accounts receivable, net (3,600,000) (16,800,000)     (5,559,960) (488,829) 923,553 (400,000) 47,400,000 13,400,000 (9,600,000)
Inventories (21,100,000) (30,900,000)     4,234,671 (3,218,497) (121,258) 44,900,000 5,600,000 5,600,000 (23,400,000)
Prepaid and other current assets (20,600,000) 400,000     293,185 (372,676) (44,043) (13,500,000) 1,100,000 3,900,000 2,800,000
Other assets           42,162 (78,469)        
Accounts payable (6,300,000) 35,300,000     2,138,753 1,002,960 7,412,371 (12,500,000) (33,700,000) (13,100,000) 22,500,000
Accrued expenses and taxes 53,100,000 38,300,000     1,935,168 (2,599,840) (394,135) (14,000,000) 1,600,000 (3,700,000) (4,000,000)
Income taxes payable         (255,007) 356,420 523,190        
Long-term assets, liabilities and other, net 4,600,000 3,000,000     (239,527) (492,783) (470,770) (5,400,000) 4,500,000 (800,000) (5,600,000)
Total adjustments to net (loss) earnings 88,900,000 77,800,000           (173,900,000) 835,100,000 10,200,000 60,300,000
Net cash provided by (used in) operating activities 33,800,000 74,500,000 14,524,122 19,109,391 20,162,068 (2,331,194) 16,776,027 21,400,000 54,400,000 6,800,000 46,900,000
Cash flows from investing activities:                      
Capital expenditures (13,900,000) (12,600,000) (3,152,304) (1,876,615) (3,809,229) (4,654,754) (3,123,951) (17,900,000) (25,400,000) (500,000) (19,800,000)
Net cash paid for businesses acquired (30,900,000) (9,200,000)       0 244,556 (14,100,000) (32,700,000) 0 (285,200,000)
Investment in joint venture (5,300,000) 0           0 0 0 0
Proceeds from the sale of property and equipment 600,000 500,000     10,050 28,692 0 2,200,000 8,500,000 0 400,000
Change in restricted cash and marketable securities 200,000 1,200,000           (1,200,000) 300,000 600,000 1,200,000
Other, net 200,000 0           (2,900,000) (1,900,000) (200,000) 0
Net cash used in investing activities (49,100,000) (20,100,000)     (3,799,179) (4,626,062) (2,879,395) (33,900,000) (51,200,000) (100,000) (303,400,000)
Cash flows from financing activities:                      
Increase in borrowings 80,600,000 47,900,000           64,700,000 279,400,000 300,000 133,100,000
Payment of borrowings (99,300,000) (138,000,000)           (143,800,000) (111,000,000) (4,100,000) (149,100,000)
Net change in related party note payable           0 (390,790)        
Checks written in excess of bank balance         (820,496) (129,538) 856,675        
Repayment of long-term debt     (187,500) (187,500) (225,000) (600,000) (1,125,000)        
Dividends paid to shareholders         (4,746,848)            
Excess tax benefits from stock-based compensation         545,939            
Redemption and retirement of common stock         (57,751) 0 (14,496,739)        
Cash advances and interest on shareholder note receivables     (514,057) (736,480) (805,501)            
Issuance of common stock, net of shareholder note receivables     83,262 69,864 379,220 83,643 983,343        
Net proceeds from the sale of the 10% Senior Unsecured Notes due 2018 0 0           0 0 0 250,000,000
Net proceeds from the sale of the 10% Senior Secured Notes due 2013 0 0           0 742,200,000 0 0
Payments on long-term lines of credit 0 0 (8,865,145) (39,484,542) (39,484,542) (96,254,508) (3,733,485) 0 (755,500,000) 0 0
Sale of the 8.5% Senior Notes due 2021 500,000,000 0           0 0 0 0
Net proceeds on long-term lines of credit 348,200,000 0 4,129,283 29,500,047 34,235,909 97,544,422 12,428,065 0 0 0 0
Redemption of the 11% Senior Secured Notes due 2013 (753,300,000) 0           0 0 0 0
Fees paid in connection with new debt facilities (58,700,000) 0           (4,100,000) (33,800,000) 0 (9,500,000)
Equity investment by Nortek Holdings, Inc. 0 0           0 4,200,000 0 0
Payment of minimum withholding taxes in connection with vesting of restricted stock (2,700,000) 0           0 0 0 0
Other, net 0 (700,000)           200,000 100,000 0 100,000
Net cash provided by (used in) financing activities 14,800,000 (90,800,000) (5,354,157) (10,838,611) (10,979,070) 644,019 (5,477,931) (83,000,000) 125,600,000 (3,800,000) 224,600,000
Effect of exchange rate changes on cash and cash equivalents         3,747 (451,642) 62,328        
Net change in unrestricted cash and cash equivalents (500,000) (36,400,000) 6,017,661 6,394,165 5,387,566 (6,764,879) 8,481,029 (95,500,000) 128,800,000 2,900,000 (31,900,000)
Unrestricted cash and cash equivalents at the beginning of the period 57,700,000 89,600,000 7,241,377 1,853,811 1,853,811 8,618,690 137,661 182,200,000 53,400,000 86,700,000 89,600,000
Unrestricted cash and cash equivalents at the end of the period 57,200,000 53,200,000 13,259,038 8,247,976 7,241,377 1,853,811 8,618,690 86,700,000 182,200,000 89,600,000 57,700,000
Cash paid during the year for:                      
Interest paid 58,200,000 44,300,000 62,791 214,902 470,176 644,069 437,100 116,100,000 118,500,000 100,000 86,600,000
Income taxes (refunded) paid, net (5,500,000) 11,600,000 5,966,073 1,615,669 4,154,481 2,482,371 2,114,775 12,800,000 10,700,000 200,000 18,400,000
Cash Received During The Year For                      
Interest         8,870 32,693 217,342        
Income taxes     $ 24,732 $ 109,787 $ 708,339 $ 177,715 $ 159,613